USA flag logo/image

An Official Website of the United States Government

THE PROPOSED SBIR PROJECT IS DESIGNED TO DEVELOP AN ASSAY WHICH WILL ALLOW THE…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
461
Program Year/Program:
1983 / SBIR
Agency Tracking Number:
461
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Vestar, Inc.
650 Cliffside Drive San Dimas, CA 91773
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1983
Title: THE PROPOSED SBIR PROJECT IS DESIGNED TO DEVELOP AN ASSAY WHICH WILL ALLOW THE DIRECT MEASUREMENT OF A COMMON CARCINOGEN BOUND TO DNA (DNA-ADDUCT) AND ESTABLISH THE CORRELATION BETWEEN THE BURDEN OF THIS ADDUCT AND THE INDUSTRIAL EXPOSURE TO THE
Agency: HHS
Contract: N/A
Award Amount: $48,911.00
 

Abstract:

THE PROPOSED SBIR PROJECT IS DESIGNED TO DEVELOP AN ASSAY WHICH WILL ALLOW THE DIRECT MEASUREMENT OF A COMMON CARCINOGEN BOUND TO DNA (DNA-ADDUCT) AND ESTABLISH THE CORRELATION BETWEEN THE BURDEN OF THIS ADDUCT AND THE INDUSTRIAL EXPOSURE TO THE CARCINOGEN. THE PROJECT WILL BE PERFORMED IN THREE PHASES: ASSAY DEVELOPMENT; ASSAY OPTIMIZATION, AND CORRELATION OF ADDUCT BURDEN WITH EXPOSUREINDEX; COMMERCIALIZATION. THE THIRD PHASE WILL BE FUNDED BYA COMMERCIAL PARTNER. COMMERCIALIZATION WILL ENTAIL A SERVICE WHICH MEASURES THE DNA-ADDUCT BURDEN IN INDIVIDUALS.THE OBJECTIVE OF THIS PHASE I RESEARCH IS TO DEVELOP AND DEMONSTRATE AN ASSAY SYSTEM THAT IS CAPABLE OF MEASURING IN HUMANS THE DNA ADDUCTS OF THE PREVALENT CHEMICAL CARCINOGEN,BENZO(A)PYRENE (B(A)P). B(A)P BECOMES MUTAGENIC AND CARCINOGENIC AFTER METABOLIC ACTIVATION. THE COVALENT BINDING OF THE ACTIVATED METABOLITE TO CELLULAR DNA IS CONSIDERED TO BE AN IMPORTANT STEP IN THE INITIATION OF MALIGNANT TRANSFORMATION. IF THESE COVALENT ADDUCTS TO DNA CAN BE DIRECTLY MONITORED IN PEOPLE AT RISK TO CARCINOGEN EXPOSURE, ACTIONS CAN BE TAKEN TO PREVENT FURTHEREXPOSURE AND POSSIBLY AVOID THE INDUCTION OF CANCER AT A OF BIFUNCTIONAL REAGENTS (EDTA-PH-B[OH]2) CONTAINING A POWERFUL METAL CHELATING EDTA MOIETY LINKED TO GROUP THAT REACTS WITH THE CIS-8, 9-DIHYDRODIOL PORTION OF THE GUANOSINE ADDUCT (BPDE-DG) OF A B(A)P METABOLITE. BLOOD (10 ML) IS DRAWN FROM B(A)P EXPOSED HUMANS, LYMPHOCYTES ARE SEPARATED, AND DNA IS EXTRACTED AND ENZYMATICALLY HYDROLYSEDTO NUCLEOSIDES BY CONVENTIONAL METHODS. THE EDTA-PH-B(OH)2 IS COMPLEXED WITH A SHORT-LIVED METAL ISOTOPE (E.G.(111)IN, (99)TC) AND THEN CONDENSED WITH THE BPDE-DG TO FORM A CYCLICBORONATE ESTER. THE STABLE COMPLEX OF THE RADIOACTIVE METALEDTA-PH(OH)2 - BPDE-DG IS CHROMATOGRAPHICALLY SEPARATED FROMOTHER IMPURITIES AND DETECTED. WITH A DETECTABILITY CRITERION OF 100 DPM, 5 X 10(4) MOLECULES OF THE DNA ADDUCT CAN BE DETECTED IF (99)TC IS USED. THE GOAL OF THE PHASE I RESEARCH IS TO ATTAIN A DETECTABILITY LEVEL OF 10(7) MOLECULES SO THAT ONE B(A)P ADDUCT CAN BE DETECTED PER CELL FROM 10 ML OF BLOOD. WHEN THE CHEMICAL ASSAY IS DEMONSTRATED "IN VITRO", IT WILL BE USED TO MEASURE THE ADDUCTS IN BLOOD SAMPLES DRAWN FROM TWO COKE OVEN WORKERS. EPIDEMIOLOGY STUDIES CORRELATING THE ADDUCT BURDEN WITH CUMULATION OCCUPATION DOSE WILL BE CONDUCTED IN PHASE II.

Principal Investigator:

Richard f. hammen
PRINCIPAL INVESTIGATOR
2137926101

Business Contact:

Small Business Information at Submission:

Vestar Research Inc.
939 East Walnut Street Pasadena, CA 91106

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No